Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 1997

View Archived Issues

Shaman patents new antifungal agents

New anticonvulsants from Howard University

Celltech reports new PDE IV inhibitors

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Human IL-9 reported in patent literature

Sumitomo reports novel hCNTF variant

Suntory reports new agents for circulatory disorders

New 5-HT1A receptor ligands reported by Bayer

New cardiovascular agents from Sigma-Tau

Company Profile: CyberChemics

Company Profile: Calydon

n-Docosanol efficacy demonstrated in herpes labialis

Efficacy of Fujirebio antiulcer drug demonstrated

Hoechst launches antidiabetic drug in Germany

Function of breast cancer gene described

Viracept licensed to Roche

Hybridon granted patent coverage for orally administered hybrid compounds

First market introductions for Bondronat

Millennium and ChemGenics merge

New market for Mivacron

Synsorb product enters clinical trials

Allelix refocuses drug development program

Asta seeks rights to impotency Rx

GS-840 progresses through clinical trials

URSO to be evaluated as chemopreventive for colorectal cancer

Altus receives grant for nerve agent neutralization

Sequana and PE Applied Biosystems form Chinese joint venture

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...